Alessandra Oliva

Pubblicazioni

Titolo Pubblicato in Anno
Is albumin predictor of mortality in COVID-19? ANTIOXIDANTS & REDOX SIGNALING 2020
Hypoalbuminemia, coagulopathy and vascular disease in covid-19 CIRCULATION RESEARCH 2020
Nox2 activation in covid-19 REDOX BIOLOGY 2020
Superinfections in patients treated with teicoplanin as anti SARSCoV2 AGENT EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2020
Antimicrobial essential oil formulation: chitosan coated nanoemulsions for nose to brain delivery PHARMACEUTICS 2020
Cefiderocol for compassionate use in the treatment of complicated infections caused by extensively and pan-resistant Acinetobacter baumannii JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE 2020
Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature INFECTION 2020
Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study) OPEN FORUM INFECTIOUS DISEASES 2020
False-negative RT-PCR in SARS-CoV-2 disease: experience from an Italian COVID-19 unit ERJ OPEN RESEARCH 2020
Are Follow-Up Blood Cultures useful in the antimicrobial management of gram negative bacteremia? A reappraisal of their role based on current knowledge ANTIBIOTICS 2020
Nox2 activation in Covid-19 REDOX BIOLOGY 2020
Is Albumin Predictor of Mortality in COVID-19? ANTIOXIDANTS & REDOX SIGNALING 2020
Hypoalbuminemia, coagulopathy, and vascular disease in COVID-19 CIRCULATION RESEARCH 2020
Is teicoplanin a complementary treatment option for COVID-19? The question remains INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2020
Follow-up blood cultures in gram-negative bacilli bacteremia: Are they needed for critically ill patients? MINERVA ANESTESIOLOGICA 2020
Clinical efficacy of ceftolozane-tazobactam versus other active agents for the treatment of bacteremia and nosocomial pneumonia due to drug-resistant pseudomonas aeruginosa CLINICAL INFECTIOUS DISEASES 2020
Effects of non-invasive ventilation on renal and endothelial function in patients with respiratory failure EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 2020
Secondary antibiotic resistance, correlation between genotypic and phenotypic methods and Treatment in Helicobacter pylori infected patients: A retrospective study. ANTIBIOTICS 2020
What are the treatment options for resistant Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria? EXPERT OPINION ON PHARMACOTHERAPY 2020
Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 2019

Interessi di ricerca

Nosocomial infections; clinical microbiology; multi-drug resistant pathogens; translational research; microbial translocation during infections

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma